174 related articles for article (PubMed ID: 36144509)
1. Evaluation of the In Vitro Wound-Healing Potential of Ayahuasca.
Gonçalves J; Luís Â; Gallardo E; Duarte AP
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144509
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Study of the Bioavailability and Bioaccessibility of the Main Compounds Present in Ayahuasca Beverages.
Gonçalves J; Castilho M; Rosado T; Luís Â; Restolho J; Fernández N; Gallardo E; Duarte AP
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577025
[TBL] [Abstract][Full Text] [Related]
3. Gas chromatographic analysis of dimethyltryptamine and beta-carboline alkaloids in ayahuasca, an Amazonian psychoactive plant beverage.
Pires AP; De Oliveira CD; Moura S; Dörr FA; Silva WA; Yonamine M
Phytochem Anal; 2009; 20(2):149-53. PubMed ID: 19140116
[TBL] [Abstract][Full Text] [Related]
4. Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness.
Hamill J; Hallak J; Dursun SM; Baker G
Curr Neuropharmacol; 2019; 17(2):108-128. PubMed ID: 29366418
[TBL] [Abstract][Full Text] [Related]
5. Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca.
McKenna DJ; Towers GH; Abbott F
J Ethnopharmacol; 1984 Apr; 10(2):195-223. PubMed ID: 6587171
[TBL] [Abstract][Full Text] [Related]
6. Determination of N,N-dimethyltryptamine and beta-carboline alkaloids in human plasma following oral administration of Ayahuasca.
Yritia M; Riba J; Ortuño J; Ramirez A; Castillo A; Alfaro Y; de la Torre R; Barbanoj MJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 779(2):271-81. PubMed ID: 12361741
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective potential of Ayahuasca and untargeted metabolomics analyses: applicability to Parkinson's disease.
Katchborian-Neto A; Santos WT; Nicácio KJ; Corrêa JOA; Murgu M; Martins TMM; Gomes DA; Goes AM; Soares MG; Dias DF; Chagas-Paula DA; Paula ACC
J Ethnopharmacol; 2020 Jun; 255():112743. PubMed ID: 32171895
[TBL] [Abstract][Full Text] [Related]
8. Kinetic profile of N,N-dimethyltryptamine and β-carbolines in saliva and serum after oral administration of ayahuasca in a religious context.
Lanaro R; Mello SM; da Cunha KF; Silveira G; Corrêa-Neto NF; Hyslop S; Cabrices OG; Costa JL; Linardi A
Drug Test Anal; 2021 Mar; 13(3):664-678. PubMed ID: 33119972
[TBL] [Abstract][Full Text] [Related]
9. Ritualistic Use of Ayahuasca versus Street Use of Similar Substances Seized by the Police: A Key Factor Involved in the Potential for Intoxications and Overdose?
Lanaro R; Calemi DB; Togni LR; Costa JL; Yonamine M; Cazenave Sde O; Linardi A
J Psychoactive Drugs; 2015; 47(2):132-9. PubMed ID: 25950593
[TBL] [Abstract][Full Text] [Related]
10. Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges.
McKenna DJ
Pharmacol Ther; 2004 May; 102(2):111-29. PubMed ID: 15163593
[TBL] [Abstract][Full Text] [Related]
11. Immunological Modulation and Control of Parasitaemia by Ayahuasca Compounds: Therapeutic Potential for Chagas's Disease.
Katchborian-Neto A; Santos MFC; Vilas-Boas DF; Dos Santos EG; Veloso MP; Bueno PCP; Caldas IS; Soares MG; Dias DF; Chagas-Paula DA
Chem Biodivers; 2022 Oct; 19(10):e202200409. PubMed ID: 36163588
[TBL] [Abstract][Full Text] [Related]
12. The globalization of ayahuasca: harm reduction or benefit maximization?
Tupper KW
Int J Drug Policy; 2008 Aug; 19(4):297-303. PubMed ID: 18638702
[TBL] [Abstract][Full Text] [Related]
13. Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant.
Rossi GN; Guerra LTL; Baker GB; Dursun SM; Saiz JCB; Hallak JEC; Dos Santos RG
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358968
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Cytotoxicity of Ayahuasca Beverages.
Simão AY; Gonçalves J; Gradillas A; García A; Restolho J; Fernández N; Rodilla JM; Barroso M; Duarte AP; Cristóvão AC; Gallardo E
Molecules; 2020 Nov; 25(23):. PubMed ID: 33260723
[TBL] [Abstract][Full Text] [Related]
15. Ayahuasca Lyophilization (Freeze-drying) Protocol with Pre- and Post-procedure Alkaloids Quantification.
Daldegan-Bueno D; Favaro VM; Tófoli LF; Sussulini A; Cassas F; Oliveira MGM
J Psychoactive Drugs; 2022; 54(3):278-283. PubMed ID: 34530685
[TBL] [Abstract][Full Text] [Related]
16. Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca.
Riba J; McIlhenny EH; Valle M; Bouso JC; Barker SA
Drug Test Anal; 2012; 4(7-8):610-6. PubMed ID: 22514127
[TBL] [Abstract][Full Text] [Related]
17. Mutagenicity of Ayahuasca and Their Constituents to the Salmonella/Microsome Assay.
Kummrow F; Maselli BS; Lanaro R; Costa JL; Umbuzeiro GA; Linardi A
Environ Mol Mutagen; 2019 Apr; 60(3):269-276. PubMed ID: 30488498
[TBL] [Abstract][Full Text] [Related]
18. Identification of N,N-dimethyltryptamine and beta-carbolines in psychotropic ayahuasca beverage.
Gambelunghe C; Aroni K; Rossi R; Moretti L; Bacci M
Biomed Chromatogr; 2008 Oct; 22(10):1056-9. PubMed ID: 18506697
[TBL] [Abstract][Full Text] [Related]
19. Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking.
Kuypers KP; Riba J; de la Fuente Revenga M; Barker S; Theunissen EL; Ramaekers JG
Psychopharmacology (Berl); 2016 Sep; 233(18):3395-403. PubMed ID: 27435062
[TBL] [Abstract][Full Text] [Related]
20. Hypotheses regarding the mechanisms of ayahuasca in the treatment of addictions.
Liester MB; Prickett JI
J Psychoactive Drugs; 2012; 44(3):200-8. PubMed ID: 23061319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
